Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review Luis Gutiérrez-Rojas; Jesús José de la Gándara Martín; Luisa García Buey; Juan I. Uriz Otano; Álvaro Mena; Carlos Roncero;

Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents Silvia Goñi Esarte; Regina Juanbeltz; José Manuel Zozaya; Juan Isidro Úriz; Jesús Castilla; José Ignacio Herrero;

mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis E Screening in patients with immune impairment and increased transaminases levels) Mar Riveiro-Barciela; Luisa Roade; Joan Martínez-Camprecios; Judit Vidal-González; Basilio Rodríguez-Diez; Manel Perelló; Guillermo Ortí; Virginia Robles-Alonso; Cristina Berastegui; Jordi Navarro; Fernando Martínez-Valle; Itxarone Bilbao; Lluis Castells; Meritxell Ventura-Cots; Jordi Llaneras; Ariadna Rando-Segura; Xavier Forns; Sabela Lens; Martín Prieto; María García-Eliz; Arkaitz Imaz; Francisco Rodríguez-Frías; Maria Buti; Rafael Esteban;